Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues
| Class:Id | LiteratureReference:9957432 |
|---|---|
| _displayName | Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues |
| _timestamp | 2025-06-18 23:10:27 |
| author | [Person:9957476] Nürge, Benjamin [Person:9957335] Schulz, Alan Lennart [Person:9957425] Kaemmerer, Daniel [Person:1980014] Sänger, J [Person:9957439] Evert, Katja [Person:5618263] Schulz, Stefan [Person:9957488] Lupp, Amelie |
| created | [InstanceEdit:9957474] Shamovsky, Veronica, 2025-06-18 |
| journal | PLoS One |
| pages | e0246939 |
| pubMedIdentifier | 33606748 |
| title | Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues |
| volume | 16 |
| year | 2021 |
| (literatureReference) | [Summation:9957319] The complement component 5a receptor 1 (C5AR1; also known as... [Summation:9957396] Vilobelimab is a chimeric human/mouse IgG4‑kappa monoclonal ... |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues (9957432)
